These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7577710)

  • 21. Characterization of Chinese hamster ovary cell lines expressing human steroid 5 alpha-reductase isozymes.
    Thigpen AE; Cala KM; Russell DW
    J Biol Chem; 1993 Aug; 268(23):17404-12. PubMed ID: 8394341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture.
    Berthaut I; Mestayer C; Portois MC; Cussenot O; Mowszowicz I
    Prostate; 1997 Aug; 32(3):155-63. PubMed ID: 9254894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FCE 28260, a new 5 alpha-reductase inhibitor: in vitro and in vivo effects.
    Giudici D; Briatico G; Cominato C; Zaccheo T; Iehlè C; Nesi M; Panzeri A; di Salle E
    J Steroid Biochem Mol Biol; 1996 Jun; 58(3):299-305. PubMed ID: 8836165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FR146687, a novel steroid 5 alpha-reductase inhibitor: in vitro and in vivo effects on prostates.
    Nakayama O; Hirosumi J; Chida N; Takahashi S; Sawada K; Kojo H; Notsu Y
    Prostate; 1997 Jun; 31(4):241-9. PubMed ID: 9180934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning, expression and characterization of rhesus macaque types 1 and 2 5alpha-reductase: evidence for mechanism-based inhibition by finasteride.
    Ellsworth KP; Azzolina BA; Cimis G; Bull HG; Harris GS
    J Steroid Biochem Mol Biol; 1998 Sep; 66(5-6):271-9. PubMed ID: 9749833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of type I 5 alpha-reductase activity in DU145 human prostatic adenocarcinoma cells.
    Kaefer M; Audia JE; Bruchovsky N; Goode RL; Hsiao KC; Leibovitch IY; Krushinski JH; Lee C; Steidle CP; Sutkowski DM; Neubauer BL
    J Steroid Biochem Mol Biol; 1996 May; 58(2):195-205. PubMed ID: 8809201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR.
    Bramson HN; Hermann D; Batchelor KW; Lee FW; James MK; Frye SV
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1496-502. PubMed ID: 9316864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride.
    Gisleskog PO; Hermann D; Hammarlund-Udenaes M; Karlsson MO
    Clin Pharmacol Ther; 1998 Dec; 64(6):636-47. PubMed ID: 9871428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer.
    Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A
    Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Finasteride inhibits 5 alpha-reductase activity in human dermal fibroblasts: prediction of its therapeutic application in androgen-related skin diseases.
    Nguyen QH; Chen T; Wang X; Chen Y; Chien P
    Int J Dermatol; 1995 Oct; 34(10):720-5. PubMed ID: 8537164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal effects of turosteride, a 5 alpha-reductase inhibitor, in the rat.
    di Salle E; Giudici D; Briatico G; Ornati G; Panzeri A
    J Steroid Biochem Mol Biol; 1993 Nov; 46(5):549-55. PubMed ID: 8240976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four-amino acid segment in steroid 5 alpha-reductase 1 confers sensitivity to finasteride, a competitive inhibitor.
    Thigpen AE; Russell DW
    J Biol Chem; 1992 Apr; 267(12):8577-83. PubMed ID: 1314830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CGP 53153: a new potent inhibitor of 5alpha-reductase.
    Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Enzyme inhibition in the drug therapy of benign prostatic hyperplasia].
    Drsata J
    Cas Lek Cesk; 2002 Oct; 141(20):630-5. PubMed ID: 12515038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actions of 5alpha-reductase inhibitors on the epididymis.
    Robaire B; Henderson NA
    Mol Cell Endocrinol; 2006 May; 250(1-2):190-5. PubMed ID: 16476520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
    Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism based representation of the active site of 5 alpha-reductase (5AR).
    Ahmed S; Denison S
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2615-70. PubMed ID: 9873591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic analysis of steroid 5alpha-reductase activity at neutral pH in benign prostatic hyperplastic tissue: evidence for type I isozyme activity in the human prostate.
    Span PN; Benraad ThJ ; Sweep CG; Smals AG
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):103-8. PubMed ID: 8645608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
    Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
    J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.